LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Lawrence Livermore National Laboratory has joined the international Human Vaccines Project, bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response.

Scientists model ‘true prevalence’ of COVID-19 throughout pandemic

Scientists have developed a statistical framework that incorporates key COVID-19 data to model the true prevalence of this disease in the U.S. Their approach projects that in the U.S. as many as 60% of COVID-19 cases went undetected as of March 7, 2021.